Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD84 antisense RNA 1 (CD84-AS1) is a long non-coding RNA (lncRNA) gene that transcribes RNA molecules complementary to the CD84 sense transcript. CD84-AS1 belongs to the family of antisense lncRNAs and is affiliated with regulatory functions at the transcriptional or post-transcriptional level. While the specific biological significance and functions of CD84-AS1 have not been exhaustively defined, antisense lncRNAs commonly participate in regulation of gene expression by interacting with their sense mRNAs or chromatin. There are currently no established disease associations, therapeutic uses, or interacting drugs for CD84-AS1. CD84-AS1 should not be confused with the protein-coding gene CD84 (a cell surface receptor with known roles in the immune system). CD84-AS1 is a non-coding RNA gene, not a classical drug or antibody target, and generally not considered a therapeutic target in current biomedical contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD84 antisense RNA 1 (CD84-AS1).